Search research articles

Search research articles

Related Experiment Videos

Clinical aspects of ECL-cell abnormalities.

B I Hirschowitz¹

¹Division of Gastroenterology and Hepatology, University of Alabama at Birmingham 35294-0007, USA.

The Yale Journal of Biology and Medicine

|August 26, 1999

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Vitamin B12 deficiency in hypersecretors during long-term acid suppression with proton pump inhibitors.

Alimentary pharmacology & therapeutics·2008

Same author

Chromogranin A in patients with acid hypersecretion and/or hypergastrinaemia.

Alimentary pharmacology & therapeutics·2007

Same author

Usual and unusual causes of duodenal ulcer.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2003

Same author

Minor effects of Helicobacter pylori on gastric secretion and dose of lansoprazole during long-term treatment in ZE and non-ZE acid hypersecretors.

Alimentary pharmacology & therapeutics·2002

Same author

Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study.

Alimentary pharmacology & therapeutics·2001

Same author

Pernicious anemia and stomach cancer.

Scandinavian journal of gastroenterology·2001

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Enterochromaffin-like (ECL) cell carcinoids in pernicious anemia are typically benign and reversible. In Zollinger-Ellison syndrome, carcinoids are usually non-malignant, but large, independent tumors can be cancerous.

Area of Science:

Gastroenterology
Endocrinology
Oncology

Background:

Hypergastrinemia causes ECL cell hyperplasia, leading to pernicious anemia (PA) or Zollinger-Ellison syndrome (ZES).
ECL cell carcinoids develop in 5-10% of PA patients and in Zollinger-Ellison syndrome patients with MEN-I.
Most carcinoids associated with PA are gastrin-dependent and benign.

Purpose of the Study:

To differentiate the clinical and biological behavior of ECL cell carcinoids in PA versus ZES.
To inform management strategies for different types of ECL cell carcinoids.

Main Methods:

Review of existing literature on ECL cell hyperplasia, carcinoids, PA, and ZES.
Analysis of carcinoid characteristics, including dependency on gastrin, size, multiplicity, and malignancy potential.

Related Experiment Videos

Main Results:

PA-associated carcinoids are small, multicentric, gastrin-dependent, and generally benign, often reversible with antrectomy.
ZES-associated carcinoids, even in MEN-I, rarely pose a malignancy threat.
Single, large, non-gastrin-dependent carcinoids are biologically distinct and frequently malignant.

Conclusions:

Small, multicentric carcinoids in PA and ZES generally warrant a conservative approach.
Large, solitary, non-gastrin-dependent carcinoids require careful evaluation due to their malignant potential.